Back to User profile » Dr Shengbin Dai
Papers published by Dr Shengbin Dai:
Expression and Clinical Value of LncRNA GAPLINC in Esophageal Squamous Cell Carcinoma
Wang P, Yang S, Dai S, Ni Q, Liu H, Yu L, Lu K, Han G, Huang J
OncoTargets and Therapy 2021, 14:4039-4045
Published Date: 5 July 2021
Success of 125I-Seed Treatment in Vulvar Squamous-Cell Carcinoma with Aplastic Anemia: A Case Report
Ni Q, Pan C, Guo Q, Wang P, Sun G, Xiao S, Dai S
OncoTargets and Therapy 2020, 13:12561-12566
Published Date: 7 December 2020
Immunotherapy Combined with Chemotherapy as a Promising Therapy for a EGFR Exon 19 Deletion with MET Amplification Patient with Non-Small-Cell Lung Cancer: A Case Report
Ni Q, Pan C, Dai S, Wang P
OncoTargets and Therapy 2020, 13:3039-3044
Published Date: 9 April 2020
Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy
Zhang W, Luo YJ, Wang XL, Han GH, Wang P, Yuan W, Dai SB
Cancer Management and Research 2018, 10:2675-2682
Published Date: 14 August 2018